For the first-generation drug (ABI-H0731), I'd say the evidence, such as it is, points in the opposite direction. For the second-generation drug (ABI-H2158), it’s too soon to say.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.